Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.
AMA J Ethics. 2020;22(8):E743-750. doi:
10.1001/amajethics.2020.743.
Both physicians and pharmacists have responsibilities to ensure that opioids are prescribed and dispensed for legitimate medical purposes and to meet legal requirements.
AMA J Ethics. 2020;22(8):E675-680. doi:
10.1001/amajethics.2020.675.
Dr Travis Rieder discusses his own experiences with opioids and the ethical challenges of “legacy patients,” and Dr Stephanie Zaza, president of the American College of Preventive Medicine, discusses the future of opioid research priorities.
Palliative psychiatry can facilitate compassionate resolution of ethical conflicts in end-of-life care decision making with persons with substance use disorders.
AMA J Ethics. 2023;25(9):E678-683. doi:
10.1001/amajethics.2023.678.
Kelsey Mumford, Lin Fraser, EdD, and Gail Knudson, MD, MEd
While transgender health care has moved beyond “gender identity disorder” and “gender dysphoria” as mental illnesses, gender incongruence continues to be a source of oppression.
AMA J Ethics. 2023;25(6):E446-451. doi:
10.1001/amajethics.2023.446.